Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2005-03, Vol.49 (3), p.959-962 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 962 |
|---|---|
| container_issue | 3 |
| container_start_page | 959 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 49 |
| creator | REILLEY, Sandra WENZEL, Eric REYNOLDS, Laurie BENNETT, Beth PATTI, Joseph M HETHERINGTON, Seth |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.49.3.959-962.2005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_proquest_miscellaneous_67457104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17804138</sourcerecordid><originalsourceid>FETCH-LOGICAL-a537t-d44cdeee345d4923fa850de4954365476ecd6f1539b0eab75af047e239698b5f3</originalsourceid><addsrcrecordid>eNqFkUtv1DAURiMEokPhJ4C8gVUz2PEj8YLFaCgUaaRWamFr3SQ3jUtiD3ZCNfx6PJpRC6uuLMvnuw-fLHvL6JKxovq4Wq2XQi_5Ukuda1UsC0rls2zBqK5yJbV6ni0oVSoXFRUn2asY72i6S01fZidMlkVVVXqRbS-36PIN1Dickc8-IjmPDQwwWe_I9TS3O-I7MvVIrqHDaUfAteSqhzBC439ah5NtyFXwnR1wT95gZ2v4M49QE-vIBcIw9Tvyww-zmxBDfJ296GCI-OZ4nmbfv5zfrC_yzeXXb-vVJgfJyylvhWhaRORCtkIXvINK0haFloIrKUqFTas6JrmuKUJdSuioKLHgWumqlh0_zT4d6m7nesS2QTcFGMw22BHCzniw5v8XZ3tz638bmdrJKuU_HPPB_5oxTma0scFhAId-jkaVQpaMiidBViYBjO8rygPYBB9jwO5hGEbN3qlJTo3Qhpvk1CSnZu805YpDDuJYmDs_B5c-7snQu3_Xf2x1NJ-A90cA9sK7AK6x8ZFTslK6ZIkjB663t_29DWjSGAageWjK_wIu4sXx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17804138</pqid></control><display><type>article</type><title>Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>REILLEY, Sandra ; WENZEL, Eric ; REYNOLDS, Laurie ; BENNETT, Beth ; PATTI, Joseph M ; HETHERINGTON, Seth</creator><creatorcontrib>REILLEY, Sandra ; WENZEL, Eric ; REYNOLDS, Laurie ; BENNETT, Beth ; PATTI, Joseph M ; HETHERINGTON, Seth</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.49.3.959-962.2005</identifier><identifier>PMID: 15728889</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adhesins, Bacterial ; Adhesins, Bacterial - immunology ; Adolescent ; Adult ; Aged ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antibodies, Monoclonal ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - pharmacokinetics ; Area Under Curve ; Biological and medical sciences ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology ; Pharmacology. Drug treatments ; Staphylococcal Infections ; Staphylococcal Infections - therapy ; Staphylococcus aureus</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.959-962</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright © 2005 American Society for Microbiology</rights><rights>Copyright © 2005, American Society for Microbiology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a537t-d44cdeee345d4923fa850de4954365476ecd6f1539b0eab75af047e239698b5f3</citedby><cites>FETCH-LOGICAL-a537t-d44cdeee345d4923fa850de4954365476ecd6f1539b0eab75af047e239698b5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC549258/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC549258/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16586971$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15728889$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>REILLEY, Sandra</creatorcontrib><creatorcontrib>WENZEL, Eric</creatorcontrib><creatorcontrib>REYNOLDS, Laurie</creatorcontrib><creatorcontrib>BENNETT, Beth</creatorcontrib><creatorcontrib>PATTI, Joseph M</creatorcontrib><creatorcontrib>HETHERINGTON, Seth</creatorcontrib><title>Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adhesins, Bacterial</subject><subject>Adhesins, Bacterial - immunology</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antibodies, Monoclonal</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - pharmacokinetics</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Staphylococcal Infections</subject><subject>Staphylococcal Infections - therapy</subject><subject>Staphylococcus aureus</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAURiMEokPhJ4C8gVUz2PEj8YLFaCgUaaRWamFr3SQ3jUtiD3ZCNfx6PJpRC6uuLMvnuw-fLHvL6JKxovq4Wq2XQi_5Ukuda1UsC0rls2zBqK5yJbV6ni0oVSoXFRUn2asY72i6S01fZidMlkVVVXqRbS-36PIN1Dickc8-IjmPDQwwWe_I9TS3O-I7MvVIrqHDaUfAteSqhzBC439ah5NtyFXwnR1wT95gZ2v4M49QE-vIBcIw9Tvyww-zmxBDfJ296GCI-OZ4nmbfv5zfrC_yzeXXb-vVJgfJyylvhWhaRORCtkIXvINK0haFloIrKUqFTas6JrmuKUJdSuioKLHgWumqlh0_zT4d6m7nesS2QTcFGMw22BHCzniw5v8XZ3tz638bmdrJKuU_HPPB_5oxTma0scFhAId-jkaVQpaMiidBViYBjO8rygPYBB9jwO5hGEbN3qlJTo3Qhpvk1CSnZu805YpDDuJYmDs_B5c-7snQu3_Xf2x1NJ-A90cA9sK7AK6x8ZFTslK6ZIkjB663t_29DWjSGAageWjK_wIu4sXx</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>REILLEY, Sandra</creator><creator>WENZEL, Eric</creator><creator>REYNOLDS, Laurie</creator><creator>BENNETT, Beth</creator><creator>PATTI, Joseph M</creator><creator>HETHERINGTON, Seth</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050301</creationdate><title>Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers</title><author>REILLEY, Sandra ; WENZEL, Eric ; REYNOLDS, Laurie ; BENNETT, Beth ; PATTI, Joseph M ; HETHERINGTON, Seth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a537t-d44cdeee345d4923fa850de4954365476ecd6f1539b0eab75af047e239698b5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adhesins, Bacterial</topic><topic>Adhesins, Bacterial - immunology</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antibodies, Monoclonal</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - pharmacokinetics</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Staphylococcal Infections</topic><topic>Staphylococcal Infections - therapy</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>REILLEY, Sandra</creatorcontrib><creatorcontrib>WENZEL, Eric</creatorcontrib><creatorcontrib>REYNOLDS, Laurie</creatorcontrib><creatorcontrib>BENNETT, Beth</creatorcontrib><creatorcontrib>PATTI, Joseph M</creatorcontrib><creatorcontrib>HETHERINGTON, Seth</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>REILLEY, Sandra</au><au>WENZEL, Eric</au><au>REYNOLDS, Laurie</au><au>BENNETT, Beth</au><au>PATTI, Joseph M</au><au>HETHERINGTON, Seth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>49</volume><issue>3</issue><spage>959</spage><epage>962</epage><pages>959-962</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>15728889</pmid><doi>10.1128/AAC.49.3.959-962.2005</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.959-962 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67457104 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Adhesins, Bacterial Adhesins, Bacterial - immunology Adolescent Adult Aged Antibiotics. Antiinfectious agents. Antiparasitic agents Antibodies, Monoclonal Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - pharmacokinetics Area Under Curve Biological and medical sciences Female Humans Male Medical sciences Middle Aged Pharmacology Pharmacology. Drug treatments Staphylococcal Infections Staphylococcal Infections - therapy Staphylococcus aureus |
| title | Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T21%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Open-Label,%20Dose%20Escalation%20Study%20of%20the%20Safety%20and%20Pharmacokinetic%20Profile%20of%20Tefibazumab%20in%20Healthy%20Volunteers&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=REILLEY,%20Sandra&rft.date=2005-03-01&rft.volume=49&rft.issue=3&rft.spage=959&rft.epage=962&rft.pages=959-962&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.49.3.959-962.2005&rft_dat=%3Cproquest_highw%3E17804138%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17804138&rft_id=info:pmid/15728889&rfr_iscdi=true |